Since China introduced its Anti-monopoly Law (AML) in 2008, the country's continued economic rise and aggressive enforcement of the AML by the three antimonopoly enforcement agencies has established the AML as a powerful force in world markets. This is rare opportunity to hear from US and China experts, as they discuss ways to navigate the antitrust landscape in China, and how it affects U.S. companies.
Topics include:
- Overview of merger enforcement
- Perspectives on merger investigations and remedies
- Anticompetitive conduct under the Anti-monopoly Law and risks of government enforcement and private litigation
- Abuse of dominance and distribution restraints
- Implications of the draft rules on abuse of intellectual property rights
Panel participants include academic experts on China's AML from the Center for Competition Law and Policy at Shanghai Jiao Tong University, China University of Political Science and Law and Renmin University, as well as the former Special Counsel for International Trade in the Antitrust Division of the U.S. Department of Justice, and a team of senior antitrust experts from Wilson Sonsini Goodrich & Rosati (Scott Sher, Stu Chemtob, and Danny Sokol).
Topics include:
• Overview of merger enforcement
• Perspectives on merger investigations and remedies
• Anticompetitive conduct under the Anti-monopoly Law and risks of government enforcement and private litigation
• Abuse of dominance and distribution restraints
• Implications of the draft rules on abuse of intellectual property rights
Our panel participants include academic experts on China's AML from the Center for Competition Law and Policy at Shanghai Jiao Tong University, China University of Political Science and Law and Renmin University, as well as the former Special Counsel for International Trade in the Antitrust Division of the U.S. Department of Justice, and a team of senior antitrust experts from Wilson Sonsini Goodrich & Rosati (Scott Sher, Stu Chemtob, and Danny Sokol).